Your browser doesn't support javascript.
loading
Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
Bohannon, Lauren; Tang, Helen; Page, Kristin; Ren, Yi; Jung, Sin-Ho; Artica, Alexandra; Britt, Anne; Islam, Prioty; Siamakpour-Reihani, Sharareh; Giri, Vinay; Lew, Meagan; Kelly, Matthew; Choi, Taewoong; Gasparetto, Cristina; Long, Gwynn; Lopez, Richard; Rizzieri, David; Sarantopoulos, Stefanie; Chao, Nelson; Horwitz, Mitchell; Sung, Anthony.
Afiliación
  • Bohannon L; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Tang H; Duke University School of Medicine, Durham, North Carolina.
  • Page K; Department of Pediatrics, Duke University, Durham, North Carolina.
  • Ren Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Jung SH; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
  • Artica A; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Britt A; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Islam P; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Siamakpour-Reihani S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Giri V; Duke University School of Medicine, Durham, North Carolina.
  • Lew M; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Kelly M; Department of Pediatrics, Duke University, Durham, North Carolina.
  • Choi T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Long G; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Lopez R; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Rizzieri D; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Chao N; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Horwitz M; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina.
  • Sung A; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, North Carolina. Electronic address: anthony.sung@duke.edu.
Transplant Cell Ther ; 27(8): 669.e1-669.e8, 2021 08.
Article en En | MEDLINE | ID: mdl-33991725

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / Trasplante de Células Madre de Sangre del Cordón Umbilical Tipo de estudio: Observational_studies Límite: Adult / Child / Humans Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / Trasplante de Células Madre de Sangre del Cordón Umbilical Tipo de estudio: Observational_studies Límite: Adult / Child / Humans Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos